Estrogen and progestogen therapy in postmenopausal women.
This Educational Bulletin discusses the effectiveness of hormone therapy (HT) for relieving vasomotor and urogenital symptoms and the side effects associated with such treatment; considers the evidence concerning the effects of HT on the risk of osteoporosis and related fractures and on the risks of coronary artery disease, dementia, and colorectal cancer; and considers the longer term effects of HT on the risks of stroke, venous thromboembolism, and cancer of the breast, endometrium, and ovary.
D000544:Alzheimer Disease / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000517:prevention & control; D003327:Coronary Disease / Q000517:prevention & control; D016021:Epidemiologic Studies; D004967:Estrogens / Q000009:adverse effects / Q000172:deficiency / Q000627:therapeutic use*; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis / Q000188:drug therapy; D005833:Genital Neoplasms, Female / Q000139:chemically induced / Q000453:epidemiology; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause / Q000187:drug effects*; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy
D004967:Estrogens; D011372:Progestins